Aegon, Allianz Solvency II ratios diverge under coronavirus stress

Whipsawing markets roiled the asset portfolios of both Aegon and Allianz in the first quarter. But the former found its capital ratio was largely shielded from adverse effects by regulatory relief measures, a benefit not evident at the latter.

Aegon’s Solvency II ratio, the proportion of loss-absorbing own-funds to its solvency capital requirement (SCR), actually increased over the first three months of the year by seven percentage points to 208%. The insurer said the application of the

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact [email protected] or view our subscription options here: http://subscriptions.risk.net/subscribe

You are currently unable to copy this content. Please contact [email protected] to find out more.

To continue reading...

You need to sign in to use this feature. If you don’t have a Risk.net account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here: